The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions.
暂无分享,去创建一个
[1] C. Serhan. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] M. Perretti,et al. Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection , 2017, Proceedings of the National Academy of Sciences.
[3] B. Levy,et al. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. , 2016, European journal of pharmacology.
[4] P. Calder,et al. Immunopharmacology of fatty acids. , 2016, European journal of pharmacology.
[5] Derek W. Gilroy,et al. Resolution of inflammation: a new therapeutic frontier , 2016, Nature Reviews Drug Discovery.
[6] Trevor A. Mori,et al. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.
[7] C. Serhan,et al. The Protectin PCTR1 Is Produced by Human M2 Macrophages and Enhances Resolution of Infectious Inflammation. , 2016, The American journal of pathology.
[8] C. Serhan,et al. Selective identification of specialized pro-resolving lipid mediators from their biosynthetic double di-oxygenation isomers. , 2016, RSC advances.
[9] A. Sinclair,et al. Short update on docosapentaenoic acid: a bioactive long-chain n-3 fatty acid , 2016, Current opinion in clinical nutrition and metabolic care.
[10] C. Serhan,et al. Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages. , 2015, Journal of natural products.
[11] D. Prvulovic,et al. Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia? , 2015, Current neuropharmacology.
[12] C. Serhan,et al. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. , 2015, Biochimica et biophysica acta.
[13] C. Serhan,et al. Novel proresolving and tissue‐regenerative resolvin and protectin sulfido‐conjugated pathways , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] C. Serhan,et al. Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection , 2014, Proceedings of the National Academy of Sciences.
[15] C. Serhan,et al. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.
[16] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[17] D. Gilroy,et al. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. , 2014, Immunity.
[18] M. Aursnes,et al. Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator. , 2014, Organic & biomolecular chemistry.
[19] C. Serhan,et al. Resolution phase lipid mediators of inflammation: agonists of resolution. , 2013, Current opinion in pharmacology.
[20] J. Haeggström,et al. The novel 13S,14S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] C. Serhan,et al. Novel n-3 Immunoresolvents: Structures and Actions , 2013, Scientific Reports.
[22] P. Calder. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? , 2013, British journal of clinical pharmacology.
[23] T. Hansen,et al. Concise syntheses of three ω-3 polyunsaturated fatty acids , 2012 .
[24] Charles N. Serhan,et al. Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.
[25] B. Samuelsson. Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field , 2012, The Journal of Biological Chemistry.
[26] S. Proudman,et al. The Role of Fish Oils in the Treatment of Rheumatoid Arthritis , 2012, Drugs.
[27] C. Serhan,et al. Resolvins and protectins in inflammation resolution. , 2011, Chemical reviews.
[28] J. Haeggström,et al. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. , 2011, Chemical reviews.
[29] M. Fornage,et al. Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium , 2011, PLoS genetics.
[30] C. Serhan,et al. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. , 2011, The Journal of clinical investigation.
[31] M. Garg,et al. Docosapentaenoic acid (22:5n-3): a review of its biological effects. , 2011, Progress in lipid research.
[32] P. Mukherjee,et al. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.
[33] D. Gilroy,et al. Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans1 , 2009, The Journal of Immunology.
[34] M. Zdanowicz,et al. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[35] C. Serhan,et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions , 2009, The Journal of experimental medicine.
[36] P. Calder. Immunomodulation by omega-3 fatty acids. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.
[37] C. Serhan. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.
[38] Katherine B Percarpio,et al. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. , 2006, Chemistry & biology.
[39] Yan Lu,et al. Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes1 , 2006, The Journal of Immunology.
[40] J. Nettleton,et al. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. , 2005, Journal of the American Dietetic Association.
[41] P. Mukherjee,et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] Magnus Ingelman-Sundberg,et al. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. , 2004, The American journal of clinical nutrition.
[43] C. Serhan,et al. Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.
[44] A. Simopoulos. Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.
[45] C. Serhan,et al. Resolvins , 2002, The Journal of experimental medicine.
[46] S. Ferdinandusse,et al. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. , 2001, Journal of lipid research.
[47] T. A. Jacobson,et al. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. , 2001, Archives of internal medicine.
[48] C. Clish,et al. Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing , 2000, The Journal of experimental medicine.
[49] B. Samuelsson. The discovery of the leukotrienes. , 2000, American journal of respiratory and critical care medicine.
[50] S. Godtfredsen,et al. Ullmann ' s Encyclopedia of Industrial Chemistry , 2017 .
[51] M. Lagarde,et al. Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[52] C. Serhan. Lipoxin biosynthesis and its impact in inflammatory and vascular events. , 1994, Biochimica et biophysica acta.
[53] K. Nicolaou,et al. Lipoxins and Related Eicosanoids: Biosynthesis, Biological Properties, and Chemical Synthesis , 1991 .
[54] K. Nicolaou,et al. Lipoxine und verwandte Eicosanoide: Biosynthese, biologische Eigenschaften und chemische Synthese , 1991 .
[55] E. Corey,et al. A Stereoselective and Practical Synthesis of 5,6(S,S)-Epoxy-15(S)-hydroxy-7(E),9(E),11(Z),13(E)-eicosatetraenoic Acid, Possible Precursor of the Lipoxins. , 1987 .
[56] E. Corey,et al. A stereoselective and practical synthesis of 5,6(S,S)-epoxy-15(S)-hydroxy-7(E),9(E),11(Z),13(E)-eicosatetraenoic acid (4), possible precursor of the lipoxins , 1986 .
[57] H. Sprecher,et al. Synthesis of two hydroxy fatty acids from 7,10,13,16,19-docosapentaenoic acid by human platelets. , 1984, The Journal of biological chemistry.
[58] M. Hamberg,et al. Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. , 1984, Biochemical and biophysical research communications.
[59] E. Corey,et al. Total synthesis of (.+-.)-5,6-oxido-7,9-trans,11,14-cis-eicosapentaenoic acid, a possible precursor of SRSA , 1979 .
[60] B. Samuelsson,et al. Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[61] B. Samuelsson,et al. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. , 1979, Proceedings of the National Academy of Sciences of the United States of America.